• Nuo Therapeutics amended its May 29, 2026 Amended and Restated Loan and Security Agreement to reset the $325,000 Second Funding closing to Oct. 6, 2026.
• The Second Funding closed Oct. 6, 2026, delivering $325,000 and bringing total borrowings under the facility to $2 million.
• Second Closing Date changes enabled a $100,000 commitment assignment, adding three new unaffiliated lenders; director Scott M. Pittman assumed $25,000.
• Second Funding Secured Promissory Notes carry 12% annual interest, mature Dec. 31, 2028; interest is payable in warrants.
• Warrants were reallocated for the assigned $100,000 commitment, with no change to aggregate warrant coverage or key economic terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032242), on October 06, 2026, and is solely responsible for the information contained therein.